Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05848219
Status:
TERMINATED
Last Update Posted:
2023-05-08
First Post:
2023-04-27
Brief Title:
Healthcare Resource Utilization and Costs in Metastatic Melanoma Patients Initiated Dabrafenib Trametinib and Encorafenib Binimetinib
Sponsor:
Organization:
Novartis